A Safety Study of Mirikizumab (LY3074828)
Clinical trial NCT01947933 · COMPLETED
Trial details
- NCT number
- NCT01947933
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2015-02-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.